Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Sirolimus

EU orphan designation number: EU/3/17/1896   
Active ingredient: Sirolimus
Indication: Treatment of pachyonychia congenita
Sponsor: Raremoon Consulting Ltd
International House, 24 Holborn Viaduct, City of London, London EC1A 2BN, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
19/07/2017 Orphan designation EMA/OD/025/17 (2017)5160 of 17/07/2017